This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
WASHINGTON — After two years of haggling, Congress has nearly reached a deal to rein in the drug-industry middlemen known as pharmacy benefit managers. Lawmakers agreed to extend telehealth flexibilities, fund public health programs, and enact these major PBM changes as part of a government funding package they are planning to pass before the end of the year, according to four health care industry sources and two congressional aides.
The eligible patient cohorts for vaccination under the spring 2025 Covid-19 programme have been confirmed, following recommendations from government advisors. In a letter sent to community pharmacies and others, NHS England announced the spring programme will cover: adults aged 75 years and over; residents in care homes for older adults; and individuals aged six months […] The post Government confirms Covid vaccine eligibility for spring 2025 programme appeared first on The Pharmacist.
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so familiar routine of online meetings, phone calls, and deadlines has returned. But what can you do? The world, such as it is, continues to spin. So to nudge it in a better direction, we have planted ourselves in the Pharmalot cafeteria to quaff cups of stimulation.
Chronic hand eczema (CHE) is a persistent, inflammatory skin disorder characterised by redness and itching, significantly reducing quality of life (QoL). Although multiple treatments for CHE are available, significant unmet need remains in long-term disease management and symptom control unable to be addressed by the current therapies. Therefore, there is a clear demand for therapies that offer sustained relief, fewer side effects, and improved ease of use, says GlobalData, a leading data and an
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hello! Fighting back a hyper 6-year-old and his 3-year-old partner in crime as I attempt to write an intro here. My offspring say hello.
Gerresheimer, a system and solution provider and global partner for the pharma, biotech, and cosmetics industries, announced that the US Food and Drug Administration (FDA) has granted SQ Innovation Tentative Approval for Lasix ONYU. This combination product consists of a high-concentration formulation of the diuretic furosemide and the Gerresheimer on-body drug delivery device.
Dr James Davies, co-author of Medicines Shortages: Solutions for Empty Shelves from the Royal Pharmaceutical Society, suggests steps to take when dealing with medicines supply problems Medicines shortages occur for all sorts of different reasons and at any one time about 3-4% of all medicines are unavailable. While that number may be small, the impact […] The post Five things you can do when theres a medicines shortage appeared first on The Pharmacist.
104
104
Signup to get articles personalized to your interests!
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Dr James Davies, co-author of Medicines Shortages: Solutions for Empty Shelves from the Royal Pharmaceutical Society, suggests steps to take when dealing with medicines supply problems Medicines shortages occur for all sorts of different reasons and at any one time about 3-4% of all medicines are unavailable. While that number may be small, the impact […] The post Five things you can do when theres a medicines shortage appeared first on The Pharmacist.
A 12-year-old male with a history of autism spectrum disorder and chronic sinusitis presented for forehead swelling. His mother reported that she noticed progressive forehead swelling for about one month. She had followed up with the patients pediatrician and ENT and was given oral cephalexin and fluticasone nasal spray which did not make any changes in his symptoms.
When it comes to researching and navigating the complex world of drug patents, inventors and researchers often turn to various tools to find relevant information. Google Patents, with its user-friendly interface and vast database, might seem like an ideal resource. However, there are several reasons why relying solely on Google Patents can be risky, especially in the context of pharmaceutical patents.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
People who smoke both vapes and cigarettes are less likely to quit smoking compared to people who use only cigarettes or only vapes, according to a new study published inERJ Open Research. Dual users (DU), who smoke both conventional cigarettes (CC) and e-cigarettes (EC), were found to be most likely to revert to smoking only […] The post Vaping while smoking is unlikely to help users quit appeared first on The Pharmacist.
3 December 2024 Berkshire, UK, LEO Pharma, a global leader in medical dermatology, today announced that the Medicines and Healthcare Products Regulatory Agency (MHRA) has granted marketing authorisation for delgocitinib cream for the treatment of adult patients with moderate to severe Chronic Hand Eczema (CHE), for whom topical corticosteroids are inadequate or inappropriate.
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
As 2024 nears its end, the Organisation of Pharmaceutical Producers of India (OPPI) DG, Anil Matai, has shared a year-end reflection on the transformative developments in Indias healthcare landscape. According to Matai, Director General of OPPI, the year has set the stage for a more patient-centric and innovation-driven future in the healthcare sector: The year 2024 has been a pivotal chapter for Indias healthcare landscape, setting the stage for a transformative journey toward a more patient-ce
A novel drug holds promise for treating Duchenne muscular dystrophy (DMD), a rare genetic disorder that causes severe muscle degeneration. McGill University researchers have discovered that an experimental compound called K884 can boost the natural repair abilities of muscle stem cells. Current treatments can slow muscle damage, but dont address the root problem.
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
CPHI Milan the worlds largest pharma event hosted last month in Milan saw a new record attendance of 59,000 pharma executives buoyed by returning confidence and increased deal-making on site. The post Pharma prepares for CDMO growth in 2025 as CPHI Milan reports record attendance appeared first on Pharma Mirror Magazine.
Rural pharmacies and hospitals face unique challenges in maintaining adequate staffing and drug supply inventory to serve patients who often travel long distance.
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Discover the benefits of BHRT, a natural solution for hormone imbalance. Learn how it relieves menopause symptoms, improves energy, and supports overall health. The post The Benefits of Bioidentical Hormone Replacement Therapy (BHRT) appeared first on Compounding Pharmacy of America.
Discover how compounding for sports medicine provides athletes with personalized treatments for pain relief, recovery, and performance enhancement. The post A Guide to Compounded Prescriptions for Sports Medicine appeared first on Compounding Pharmacy of America.
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Novo Nordisk is investing more than $1 billion in a new production facility in Denmark. Elsewhere, drugs from Neurocrine Biosciences, Checkpoint and Galderma won new FDA approvals.
The Breakthrough Therapy Designation for Jemperli was based on Phase II clinical trial data, showing a 100% clinical complete response rate in patients with locally advanced mismatch repair deficient/microsatellite instability-high rectal cancer.
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
343 
Let's personalize your content